Free Trial

BKV (NYSE:BKV) Given New $29.00 Price Target at Barclays

BKV logo with Energy background

BKV (NYSE:BKV - Get Free Report) had its price objective lifted by Barclays from $28.00 to $29.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. Barclays's price objective would indicate a potential upside of 32.52% from the stock's previous close.

Several other brokerages have also recently weighed in on BKV. KeyCorp lowered their target price on BKV from $27.00 to $25.00 and set an "overweight" rating for the company in a report on Tuesday, March 4th. Truist Financial cut their price objective on BKV from $31.00 to $30.00 and set a "buy" rating on the stock in a report on Monday, March 17th. Eight research analysts have rated the stock with a buy rating, According to MarketBeat.com, BKV has a consensus rating of "Buy" and an average price target of $27.88.

Check Out Our Latest Stock Analysis on BKV

BKV Stock Up 6.9%

Shares of NYSE BKV traded up $1.41 during trading on Monday, hitting $21.88. The company had a trading volume of 99,545 shares, compared to its average volume of 460,495. The stock has a 50 day simple moving average of $18.77 and a 200 day simple moving average of $21.14. BKV has a 12 month low of $15.00 and a 12 month high of $26.78.

BKV (NYSE:BKV - Get Free Report) last announced its earnings results on Friday, May 9th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.15 by $0.26. The company had revenue of $216.13 million during the quarter, compared to analysts' expectations of $223.20 million. On average, equities research analysts predict that BKV will post -1.82 earnings per share for the current year.

Insider Buying and Selling at BKV

In other BKV news, insider Ethan Ngo sold 21,667 shares of the firm's stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $18.47, for a total transaction of $400,189.49. Following the completion of the sale, the insider now owns 264,341 shares of the company's stock, valued at $4,882,378.27. This trade represents a 7.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO David Tameron sold 4,409 shares of BKV stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $17.94, for a total value of $79,097.46. Following the completion of the sale, the chief financial officer now directly owns 43,370 shares of the company's stock, valued at $778,057.80. The trade was a 9.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 67,743 shares of company stock valued at $1,330,777 over the last quarter.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. California State Teachers Retirement System purchased a new position in BKV in the fourth quarter valued at $26,000. SG Americas Securities LLC acquired a new stake in BKV in the fourth quarter valued at $157,000. Corebridge Financial Inc. acquired a new stake in BKV in the fourth quarter valued at $170,000. Bank of New York Mellon Corp acquired a new stake in BKV in the fourth quarter valued at $695,000. Finally, Geode Capital Management LLC acquired a new stake in BKV in the fourth quarter valued at $7,728,000.

BKV Company Profile

(Get Free Report)

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.

Featured Articles

Analyst Recommendations for BKV (NYSE:BKV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BKV Right Now?

Before you consider BKV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.

While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines